Clinical Trial: A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907965) titled 'A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease' on Oct. 26.

Brief Summary: We are conducting this clinical trial to find out whether Guominkang-a traditional Chinese herbal formula-is safe and effective for people with diabetic kidney disease (DKD).

DKD is a common complication of diabetes, affecting 20% to 40% of patients. If not well controlled, it can lead to chronic kidney disease or even kidney failure. Current treatments mainly focus on controlling blood sugar and blood pressure, but few therapies directly target immune inflammation, which plays a key role in DKD progress...